Recent figures, as mentioned in a new BBC article, indicate that one in three expectant mothers develops anaemia - a condition linked to several serious complications, including stillbirth and postnatal depression.
To combat this, our team are helping to conduct clinical trials involving maternity wards across the UK. Participants will receive either an iron supplement or a placebo. The PANDA study aims to determine whether daily iron intake can prevent the onset of anaemia and its associated risks.
The trial is open to women in the first 16 weeks of their pregnancy with a single baby. We encourage interested individuals to consult their healthcare professionals for more information on participation.
As highlighted by Chief Investigator Prof. Simon Stanworth, from the Radcliffe Department of Medicine, "This [iron] is a very common medication, and actually even in 2025 we don't really know how to use it. There's some very common treatments and managements, we're beginning to put a lot more research and scrutiny on these now moving forward and trying to now see if we can do better."
To volunteer for the PANDA study, please call us on 01865 221107 or use the contact form available here.
Who are the clinical research group
The Clinical Research Group (CRG), is part of the Nuffield Department of Women's & Reproductive Health at the University of Oxford. We deliver high-quality, inclusive research in women’s and reproductive health, advancing evidence-based care globally through dedication and adaptability, with a patient-centred approach.
leading the project
Get involved
Click here to volunteer for the clinical study
In the press
- BBC article: Pregnancy trial to prevent anaemia launched